Could Low Altitude Predict the Use of Erythropoietin‐Stimulating Agents in Hemodialysis Patients?
Residing at LA was associated with increased ESA requirements in HD patients, suggesting that altitude may be a relevant factor in anemia management.
Authors
- Emre Yaşar (ORCID: https://orcid.org/0000-0001-8271-1831)
- Alper Azak (ORCID: https://orcid.org/0000-0001-6228-8829)
- İrem Pembegül (ORCID: https://orcid.org/0000-0002-4609-1580)
- Gülay Ulusal Okyay (ORCID: https://orcid.org/0000-0003-0770-1283)
- Sinem Girgin (ORCID: https://orcid.org/0000-0003-4341-9736)
Institutions
- Balıkesir University (TR)
- Hakkari University (TR)
- University of Health Science (KH)
- Sağlık Bilimleri Üniversitesi (TR)
- Malatya Devlet Hastanesi (TR)
- Turgut Özal University (TR)
- University of Health Sciences Antigua (AG)
Publication Details
- Journal
- Therapeutic Apheresis and Dialysis
- Published
- 2025-08-26
- DOI
- https://doi.org/10.1111/1744-9987.70075
- Primary Topic
- Erythropoietin and Anemia Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00